Cibus has closed its merger with Calyxt after stockholders of Calyxt voted in favour of all proposals regarding the merger (see AgbioNews May 23, 2023). The merger follows the closing of $118.5 million in private financing by Cibus Global. The new entity will operate under the name Cibus Inc., trade on the Nasdaq Capital Market under the ticker symbol ‘CBUS’ and be led by Cibus’ existing management team.